Health
Abbott to Expand US Manufacturing as Tariffs Loom
An Abbott Nutrition distribution center in Columbus, Ohio.
Photographer: Bing Guan/BloombergThis article is for subscribers only.
Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and diagnostics looming over the industry.
It expects to spend $500 million on two facilities, located in Illinois and Texas, Abbott said in a statement Wednesday. The investments are to expand existing plants and boost US research and development for Abbott’s transfusion business, which is responsible for screening the US blood supply.